Ashar Bhavesh 4
4 · SpringWorks Therapeutics, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-02-20$61.19/sh−1,016$62,168→ 62,053 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 15, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.15 to $61.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.